European Society for Clinical Nutrition and Metabolism

New Clinical Study Shows Unprecedented Results of ART MEDICAL's smART+ Platform, Including Significant Reduction in Length of Stay, Ventilation Days in ICU and Improved Feeding Efficacy

Retrieved on: 
Monday, July 24, 2023
ESPEN, Medicine, Nutrition, Metabolism, European Society for Clinical Nutrition and Metabolism, Malnutrition, ART, Clinical nutrition, Trial of the century, Ventilation, Acute kidney injury, Hospital, Patient, Standard of care, Risk, Mortality, ICU, Nursing care plan, Intensive care unit, Nursing, Medical device

NETANYA, Israel, July 24, 2023 /PRNewswire/ -- ART MEDICAL, an Israeli medical device company committed to its vision of detecting and preventing intensive care unit (ICU)-acquired complications such as aspiration pneumonia, malnutrition and acute kidney injury, unveiled unprecedented results on the performance of its smART+ Platform in a randomized comparative study published by the European Society for Clinical Nutrition and Metabolism's (ESPEN's) Clinical Nutrition.

Key Points: 
  • The study demonstrated the smART+ Platform can maximize feeding efficiency, reaching nearly 90% of the targeted nutrition goal and improve patient outcomes by reducing both ICU length of stay and length of ventilation by 3.3 days.
  • To offset feeding interruptions, the system calculates the resulting deficit and delivers gradual compensation to better reach the prescribed 100% nutritional target.
  • Over a two-year period, a clinical study was conducted to assess critically ill patients who were mechanically ventilated and enterally fed.
  • Nutrition, while considered important, was never directly correlated to ICU length of stay," said Liron Elia, founder and CEO of ART MEDICAL.

Herbalife Nutrition Survey Reveals Top Ten Modern Day Entrepreneurs and What Traits are Needed to Join the List

Retrieved on: 
Wednesday, September 21, 2022
Vitamins, Supplements, Health, Fitness & Nutrition, AAPOR, HLF, Club, CNN, OnePoll, NYSE, Invention, Research, Public opinion, Herbalife Nutrition, American Association for Public Opinion Research, Creativity, O, The Oprah Magazine, Company, Market Research Society, European Society for Clinical Nutrition and Metabolism, ESOMAR, Opinion, American Association, Microsoft, Bill, Foundation, Character, Facebook, Intelligence, Elon Musk, Bill & Melinda Gates Foundation, Motivation, Association, SpaceX, Multimedia, Amazon, Marketing, Ted Turner, Public relations, Online gambling, Walmart, Oxygen, Google, Apple

Herbalife Nutrition, a premier global nutrition company, released the results of its latest global entrepreneur survey today.

Key Points: 
  • Herbalife Nutrition, a premier global nutrition company, released the results of its latest global entrepreneur survey today.
  • Bill Gates, Jeff Bezos and Steve Jobs topped the list as the three most influential entrepreneurs in modern times.
  • The survey also asked respondents to compare modern entrepreneurs to the entrepreneurial luminaries of previous generations.
  • The survey, which included responses from 2,000 Americans, revealed some interesting differences in how respondents view entrepreneurs across countries.

Herbalife Nutrition Commissioned a Survey and Found that 88 Percent of Respondents said, "People Who Want to Be Successful, Can't Be Afraid to Make Mistakes"

Retrieved on: 
Wednesday, May 18, 2022
People, Small business, Market Research Society, American Association for Public Opinion Research, Company, Research, HLF, ESOMAR, Multimedia, Public opinion, European Society for Clinical Nutrition and Metabolism, Learning, Association, OnePoll, Opinion, Herbalife Nutrition, Marketing, AAPOR, Nutrition, American Association, DeSimone, Growth, NYSE, Online shopping, Tutoring

LOS ANGELES, May 18, 2022 /PRNewswire/ -- Herbalife Nutrition, a premier global nutrition company that has been changing people's lives with great nutrition products and a business opportunity for its independent distributors since 1980, has released the results of its fourth annual global entrepreneur survey. Overwhelmingly, respondents agreed that a secret to success is resiliency and the ability to seize opportunities to learn and improve. One of the key takeaways from the global survey revealed that 88 percent of respondents said, "people who want to be successful, can't be afraid to make mistakes," and 85 percent don't believe they'd be where they are today if they stopped trying after making a mistake.

Key Points: 
  • Overwhelmingly, respondents agreed that a secret to success is resiliency and the ability to seize opportunities to learn and improve.
  • People who want to be successful, can't be afraid to make mistakes, according to new survey findings.
  • "Our annual global entrepreneur survey reveals insights into entrepreneurial life, providing key learnings as people consider becoming their own boss," said John DeSimone, president of Herbalife Nutrition.
  • Herbalife Nutrition commissioned the global survey of 8,000 small business owners and employees from 15 countries, which was conducted by market research firm OnePoll.

Else Nutrition to Present Significant Pre-Clinical Study Abstract at 9th International Conference on Nutrition & Growth

Retrieved on: 
Monday, February 28, 2022
GLOBE, BABY, Infant, Harvard Medical School, Rambam Health Care Campus, American Association of Clinical Endocrinologists, Nutrition, TSX Venture Exchange, Gastroenterology, Hospital, Company, Toddler, World, Facebook, Child, European Society for Clinical Nutrition and Metabolism, EFSA, Diet, International Conference for Women Leaders, Society, Conference, Instagram, Knowledge, Research, Health, Medicine, Nutritionist, Pediatrics, Tel Aviv University, Amazon, Growth

The conference brings together Pediatricians, Nutritionists, Neonatologists, experts in child development and other specialists to discuss the challenges of the interplay between Nutrition and Growth in the Pediatric age group.

Key Points: 
  • The conference brings together Pediatricians, Nutritionists, Neonatologists, experts in child development and other specialists to discuss the challenges of the interplay between Nutrition and Growth in the Pediatric age group.
  • The Conference will enable the exchange of ideas and knowledge between the different disciplines for facilitating research and clinical interdisciplinary collaborations.
  • Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults.
  • Else Nutrition (formerly INDI) won the 2017 Best Health and Diet Solutions award at the Global Food Innovation Summit in Milan.

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

Retrieved on: 
Thursday, November 25, 2021
Patient, Trial of the century, Degenerative disease, Saskatchewan River Sturgeon Management Board, Face, BAD, Mentorship, ESPEN, Fresenius (company), Supervisory board, Education, JumpStart, Program, Professor, Metabolism, Critical care, Fresenius, Parenteral nutrition, Research, Transfusion medicine, Collection, Berlin, European Society for Clinical Nutrition and Metabolism, Supervision, Congress, Pharmaceutical industry

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021.

Key Points: 
  • BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021.
  • The grant is awarded to help to advance novel, community-led research in parenteral nutrition, to make a difference for critically ill patients.
  • Dr. Jos Simons, Executive Vice President at Fresenius Kabi, commented: "We are absolutely delighted to be able to award this research grant to Professor Schaller.
  • With the JUMPstart education program and research grant, Fresenius Kabi supports the next generation of clinical experts who will contribute to advancement in nutrition therapy in critically ill patients.

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

Retrieved on: 
Thursday, November 25, 2021
Patient, Trial of the century, Degenerative disease, Saskatchewan River Sturgeon Management Board, Face, BAD, Mentorship, ESPEN, Fresenius (company), Supervisory board, Education, JumpStart, Program, Professor, Metabolism, Critical care, Fresenius, Parenteral nutrition, Research, Transfusion medicine, Collection, Berlin, European Society for Clinical Nutrition and Metabolism, Supervision, Congress, Pharmaceutical industry

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021.

Key Points: 
  • BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021.
  • The grant is awarded to help to advance novel, community-led research in parenteral nutrition, to make a difference for critically ill patients.
  • Dr. Jos Simons, Executive Vice President at Fresenius Kabi, commented: "We are absolutely delighted to be able to award this research grant to Professor Schaller.
  • With the JUMPstart education program and research grant, Fresenius Kabi supports the next generation of clinical experts who will contribute to advancement in nutrition therapy in critically ill patients.

Zealand Pharma Presents Data at 2021 ESPEN Virtual Congress Demonstrating Dose-dependent Effects of Glepaglutide in Both Small and Large Intestines of Animal Models – in Contrast to Short-acting GLP-2

Retrieved on: 
Thursday, September 9, 2021

The Companys research presented at ESPEN 2021 will feature multiple posters, including one Poster of Distinction, related to glepaglutide for the treatment of short bowel syndrome (SBS).

Key Points: 
  • The Companys research presented at ESPEN 2021 will feature multiple posters, including one Poster of Distinction, related to glepaglutide for the treatment of short bowel syndrome (SBS).
  • The data presented at ESPEN demonstrate the attractive profile of glepaglutide following once-weekly dosing in humans and the dose-dependent effects on both small and large intestines in animals, underscoring its differentiation as a potential treatment option for SBS.
  • Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, development, and commercialization of peptide-based medicines.
  • Information concerning pharmaceuticals (including compounds under development) contained within this material is not intended as advertising or medical advice.

Clinical Nutrition Market - Global Outlook and Forecast 2021-2026 with Abbott Laboratories, Baxter International, B. Braun, Danone, and Nestle Health Science Dominating - ResearchAndMarkets.com

Retrieved on: 
Monday, July 19, 2021
General Health, Pharmaceutical, Health, Food and drink, Companies, Industry economics), Medical food, Nutricia, Danone, European Society for Clinical Nutrition and Metabolism, Fresenius, Nestlé, Clinical nutrition, Wellness

The global clinical nutrition market research report includes a detailed segmentation by route of administration, age group, product type, application, distributional channels, end-users, geography.

Key Points: 
  • The global clinical nutrition market research report includes a detailed segmentation by route of administration, age group, product type, application, distributional channels, end-users, geography.
  • Focusing on health and wellness, aging well, and disease prevention by consumers, healthcare providers are demanding preventive clinical nutrition products and are experiencing rapid growth.
  • Global brands such as Abbott, Nestle, Nutricia, and Fresenius Kabi offer parenteral, enteral, and oral nutrition products for infants.
  • Abbott Laboratories, Baxter International, B. Braun, Danone, and Nestle Health Science are the major players.

Clinical Nutrition Market Revenue to Cross USD 76.1 Bn by 2027: Global Market Insights Inc.

Retrieved on: 
Monday, July 19, 2021
Self-care, European Society for Clinical Nutrition and Metabolism, Clinical nutrition, Nutrition, Articles, Health, Academic disciplines

The availability of clinical nutrition products with disease-specific composition is further anticipated to channelthe clinical nutrition market growth positively in the coming years.

Key Points: 
  • The availability of clinical nutrition products with disease-specific composition is further anticipated to channelthe clinical nutrition market growth positively in the coming years.
  • Hence, market players are focused on providinghigh-quality clinical nutrition ingredients for appropriate nutrition and safety in pediatric care.
  • The clinical nutrition market for retail stores segment exceeded USD 19.2 billion in 2020 due to the better inventory options, providinginstant gratification, and no shipping costs with physical stores.
  • The growing number of people suffering from these chronic diseases would require proper clinical nutrition to meet their daily nutritional intake.

Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer

Retrieved on: 
Thursday, June 3, 2021
Clinical nutrition, GHSI, Medical food, European Society for Clinical Nutrition and Metabolism

SAN DIEGO, June 03, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (Guardion or the Company), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medical foods and medical devices, today announced the appointment of Craig J. Sheehan as its Chief Commercial Officer.

Key Points: 
  • SAN DIEGO, June 03, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (Guardion or the Company), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medical foods and medical devices, today announced the appointment of Craig J. Sheehan as its Chief Commercial Officer.
  • Mr. Sheehan joins Guardion following the Companys recent acquisition of Activ Nutritional.
  • I thank the team at Guardion for the opportunity to build toward success together, added Mr. Sheehan.
  • Guardion Health Sciences, Inc. (Nasdaq: GHSI), is a clinical nutrition and diagnostics company.